Through platelet surface molecule P‐selectin, platelets can adhere to cancer cells and bind to CD24 ligand on the natural killer (NK) cells, thus avoiding NK cell‐mediated lethal cytotoxicity and driving tumor growth.23 Here, CD24 is linked to neoplasm.